Baxter Expands Voluntary Nationwide Recall to Include Second Lot of Nexterone Injection Due to Presence of Particulate Matter

Following the issuance of a voluntary recall dated November 10, 2017 of one lot of NEXTERONE (amiodarone HCl) 150 mg/100 mL Premixed Injection, Baxter International Inc. announced today it is expanding the recall to include a second lot (NC109123) of NEXTERONE due to the potential presence of particulate matter.

https://www.fda.gov/Safety/Recalls/ucm592678.htm

Source: Food and Drug Administration - January 17, 2018 Category: Food Science Source Type: news

More News: Amiodarone | Food and Drug Administration (FDA) | Food Science